ebook Munafa Stock Market Course + Intraday & FNO calls  

       

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY

Dr. Reddy's Laboratories Ltd RDY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Dr. Reddy's Laboratories Ltd RDY

Dr Reddy's net profit down 36% on lower Revlimid sales in North America
The company attributed the decline primarily to lower lenalidomide sales in North America. The base business, excluding lenalidomide in North America, continued to deliver double-digit growth
Announcement as on 23 October 2026

Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption
Dr Reddy’s Laboratories has expanded its generic semaglutide portfolio with Obeda Pro and Obeda Plus after supplies of its original Obeda injection were halted in July for technical evaluation. The new brands are manufactured by Hetero Labs, while distribu
Announcement as on 23 October 2026

Dr Reddy’s Q2 Results: Net profit falls 36% YoY to Rs 913 crore, revenue declines marginally
Dr Reddy’s Laboratories reported a 36% year-on-year profit decline to Rs 913.4 crore in Q2 FY27, while revenue slipped 1.5%. North America weakness pressured performance, offset partly by growth in India and emerging markets, alongside biosimilar approvals
Announcement as on 23 October 2026

Dr Reddy's receives DCGI approval for esophageal cancer drug Zytorvi
Dr Reddy's Laboratories on Wednesday said it has received approval from the Drugs Controller General of India (DCGI) for Zytorvi (toripalimab), through which it aims to expand access to first-line immunotherapy for patients with advanced esophageal squamou
Announcement as on 21 October 2026

Dr Reddy's gets DCGI nod for cancer drug's second indication in India
The approval allows toripalimab with cisplatin and paclitaxel as first-line treatment for unresectable advanced, recurrent or metastatic ESCC in adults
Announcement as on 21 October 2026

Announcements by Dr. Reddy's Laboratories Ltd first page | Next page |

RDY Dr. Reddy's Laboratories Ltd current price & indicator signals

Moving Averages for Dr. Reddy's Laboratories Ltd

  • 5Day Average: 13.99
  • 12Day Average: 13.49
  • 20Day Average: 13.1
  • 50Day Average: 12.54
  • 100Day Average: 12.74
  • 150Day Average: 12.94
  • 200Day Average: 13.21

RDY Indicators & signals

Indicator MACD (12,26,9)

13.56, 13.13, 0.32
Indicator MACD is in positive zone

Indicator ADX (14)

22.22, 36.67, 23.33
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 61
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Fri Oct 2026 14.17 14.15 to 14.31 0.43% 0.54 times
29 Thu Oct 2026 14.11 14.10 to 14.33 -0.28% 0.62 times
28 Wed Oct 2026 14.15 13.69 to 14.24 2.91% 1.32 times
27 Tue Oct 2026 13.75 13.62 to 13.85 0% 1.35 times
26 Mon Oct 2026 13.75 13.60 to 13.86 4.09% 1.22 times
23 Fri Oct 2026 13.21 13.18 to 13.57 -0.15% 1.16 times
22 Thu Oct 2026 13.23 13.06 to 13.29 0.3% 1.18 times
21 Wed Oct 2026 13.19 13.15 to 13.24 -0.53% 0.63 times
20 Tue Oct 2026 13.26 13.18 to 13.35 1.38% 1.25 times
19 Mon Oct 2026 13.08 13.02 to 13.12 0.08% 0.44 times
16 Fri Oct 2026 13.07 12.94 to 13.07 1.32% 0.83 times
15 Thu Oct 2026 12.90 12.84 to 13.04 1.18% 0.81 times

Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared USA

 

Back to top